Editorial E ndothelial cells (ECs) covering the inner surface of blood and lymphatic vessels 1 create an interface between circulating blood and lymph and the surrounding tissue. Hence, ECs are crucially involved in maintaining the integrity of all tissues. In addition, the formation of new vessel, eg, during wound healing processes, is determined by ECs. 2 Thus, the maintenance of a structural and functional inner vascular EC surface is of particular importance. However, during pathological conditions ECs may be induced to undergo apoptosis, a major hallmark of the progression of atherosclerosis and other conditions. As these pathologies are the major cause of death in the Western hemisphere, 3 it is of outstanding importance to understand the fundamental mechanisms of EC apoptosis. Improved knowledge about the underlying mechanisms and signaling pathways enables physicians and scientists to combat these maladaptive mechanisms and help care for patients suffering from these diseases.
Article, see p 1551
To date, the understanding of EC apoptosis still remains elusive and fragmentary. It is an established dogma that a variety of intracellular signaling cascades, such as those involving Fas/ Fas ligand, Bax/Bad, or caspases, are responsible for EC apoptosis. 4 For example, the protein kinase B/Akt is a major effector of apoptotic inhibition by activating antiapoptotic signaling pathways of the Bcl-2 family. 4 Akt, in turn, is activated and stabilized by a variety of cellular signaling pathways. In recent years, focal adhesions (FAs) have been found to play important roles in Akt activation by their interaction with phosphatidylinositol-3-kinase, a major upstream effector of Akt. FA kinase is one important component in this interaction because it regulates cell survival via phosphatidylinositol-3-kinase/Akt signaling. 5 Besides FA kinase and other FA assemblies, a complex consisting of integrin-linked kinase (Ilk), pinch1/2, and α-parvin/β-parvin (IPP) is significant for tissue development. 6 Ilk represents the central component of this ternary complex, regulating the levels of pinch1/2 and α-parvin/β-parvin. Dependent on its molecular constitution, the IPP complex exerts divergent signaling pathways. Although being involved in a variety of signaling events, the IPP plays a prominent role in Akt signaling. 6 In this regard, the IPP complex also mediates EC survival by inhibiting apoptotic routes 7 ( Figure, A) . Although much is known about the intracellular signaling involved in apoptosis, the entire picture of the mediators controlling these processes is likely more complex. Because the extracellular matrix (ECM) surrounding ECs represents a sophisticated regulator of EC behavior, 8 it is reasonable to speculate that ECM-mediated signals via ECM proteins (eg, collagens or laminins) and intracellular ECM binding partners (eg, integrins and FAs) intervene with apoptotic regulatory pathways of ECs (Figure, B) .
In this issue of Circulation Research, de Jesus Perez et al 9 demonstrate that adenomatous poliposis coli (APC), a β-catenin-involving tumor suppressor 10, 11 with unknown functions in EC apoptosis, is crucial for the stabilization of FAs, especially for the IPP complex. Using an Apc
Min/+ mouse model, the authors unravel a mechanism that depends on the interaction between ECM proteins, specifically laminins and α3β1 integrins, resulting in the activation of Ilk. Akt is subsequently phosphorylated upon Ilk activation, thus linking the ECM-induced signaling to EC survival (Figure, A) .
This novel mechanism attributes an innovative role to APC in the stabilization and molecular regulation of FA assembly. Thereby, APC mediates inside-out signaling and, thus, is subsequently responsible for EC survival, independent of its role in canonical/noncanonical β-catenin signaling. 10 However, it should be critically scrutinized whether Ilk itself is directly responsible for this signaling. It was a common belief that Ilk possesses a kinase domain directly activating Akt. 12 In the past years, however, concerns were raised contradicting this concept. Indirect genetic evidence against a direct interaction of Ilk and Akt was provided by the group of Fässler 13 who demonstrated by point mutations in the proposed kinase domain of Ilk that this domain is dispensable for mammalian development.
14 Therefore, further studies should carefully look at the underlying mechanisms by which APC and Ilk induce Akt phosphorylation. The discovery of the precise mechanisms would inevitably strengthen the therapeutic approaches to inhibit EC apoptosis. Regardless of Ilk having a direct or indirect role in this process, the stabilization of the APC/IPP complex seems to be a prerequisite for Akt activation and subsequent inhibition of EC apoptosis.
De Jesus Perez et al 9 did not only focus on the role of FAs in EC apoptosis. They additionally addressed the highly important question of whether ECM components are involved in the stabilization of the APC/IPP complex. Their discovery, that laminins are essential for these regulations, opens up new avenues to therapeutically target apoptotic ECs, as the knowledge of involvement of laminins provides a possibility
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From Figure B) . In that regard, it should be noted that de Jesus Perez et al 9 did not provide evidence about the precise laminin isoforms involved. The pool of suspects, however, is small, because it is well-known that laminin-511, laminin-411, and laminin-3B11 are members of the subendothelial basement membrane responsible for EC integrity. In this context, Gu et al 15 demonstrated that laminin-511 and laminin-521 directly bind to α3β1 integrin and thereby activate the phosphatidylinositol-3-kinase/Akt signaling pathway, leading to EC survival in carcinoma cells. However, it will be of high significance to further evaluate the question of ECM integration, and thus the outside-in signaling pathways in the APC-dependent regulation of EC survival, because by its molecular composition, the ECM is a sensitive modulator and, hence, critical for vessel growth. 8, 16 Regarding pathological conditions such as tumor growth or atherosclerosis, the ECM dynamically changes its molecular phenotype, specifically induced by activation of proteolytic enzymes resulting in cleavage of ECM proteins, including laminins. 8 This leads to the unresolved, but important question of whether the formation of cleavage fragments changes EC survival dependent on APC/IPP signaling.
In their sophisticated analysis of intracellular signaling complexes dependent on APC and, in parallel, the investigation of ECM components involved in this mechanism, de Jesus Perez et al 9 provide novel integrin-dependent pathways. First, they provide an important inside-out signaling route via the α3β1 integrin/APC/IPP assembly, regulating the intracellular signals consequently resulting in EC survival. Second, the authors single out laminins of a variety of α3β1 
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integrin-binding ECM proteins as the prominent extracellular substrate responsible for the observed EC survival. As a third important finding, de Jesus Perez et al 9 show that APC signaling is seriously reduced under hypoxic conditions as a result of a failure of α3β1 downstream signaling. This finding confirms former results, showing that the knockout of β1 integrins results in EC apoptosis without affecting their proliferative capacity 17, 18 ( Figure C) . With regard to hypoxic conditions, however, APC could function as a Janus face regarding its role in tumor biology, a tissue characterized by prevalent hypoxic conditions. These hypoxic conditions reduce APC levels 19 leading to EC apoptosis, 19 which is a wellknown antiangiogenic mechanism. At the same time, some tumors (eg, glioblastomas, melanomas, and colon cancers) show aggressive metastasis invading vessel walls, resulting in so-called mosaic vessels. In these vessels, tumor cells residing in the vicinity of ECs have replaced ECs. 20 For that reason, tumor cells can reach the normoxic blood circulation where the APC stabilization could induce survival and distribution of aggressive tumor cells, leading to metastasis formation.
Taken together, these data identify β1 integrins as prominent mediators of EC survival. The data provided by de Jesus Perez et al 9 point to an additional important mechanism of vascular development directly mediated by a β1 integrin-dependent pathway. In future studies, it should be asked whether α3 is the α-subunit of integrin heterodimers responsible for the observed signaling. The identification of the involved integrin heterodimers would significantly stimulate clinical interventions.
As a final aspect of the study by de Jesus Perez et al, 9 the direct connection between metabolic and mechanical signaling pathways should be highlighted. The authors show that metabolic circumstances (hypoxia) lead to the downregulation of APC, which has a negative effect on the stabilization of mechanically sensitive IPP members. Therefore, metabolic cues might thoroughly alter mechanical signaling and, thus, EC behavior by modifying the ECM-cell interactions.
As a concluding remark, the article of de Jesus Perez et al 9 presents highly important new insights into EC apoptosis. They show that APC stabilizes the IPP complex located downstream of β1 integrins, an event that in turn results in Akt activation and thus inhibition of EC apoptosis. In addition, these data shed light on new outside-in and inside-out signaling routes dependent on laminins activating α3β1 integrins that interact with the APC/IPP complex. Further advances in our understanding of the role of specific laminin isoforms, as well as the direct effectors of Akt phosphorylation, will alleviate to the remaining inconsistencies and will advance the quest for new therapies in vascular disease and tumors.
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